[1]
“Clinical Experience with Sugammadex as a Neuromuscular Reversal Agent: A 10-Patient - Case Series”, Vitt Med J Case Rep, Feb. 2026, Accessed: Jun. 05, 2026. [Online]. Available: https://vmcasereports.com/vmjcr/article/view/22